Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16449474 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Condition: Bipolar Disorder
Interventions: Drug: lithium;   Drug: valproate;   Drug: bupropion;   Drug: paroxetine;   Drug: lamotrigine;   Drug: risperidone;   Drug: inositol;   Drug: tranylcypromine;   Behavioral: Cognitive Behavioral Therapy;   Behavioral: Family-focused Therapy;   Behavioral: Interpersonal and Social Rhythms Therapy

Indicates status has not been verified in more than two years